Description
An active metabolite of adefovir dipivoxil; formed from adefovir dipivoxil by CES2; inhibits cytopathogenicity induced by HSV-1 and HSV-2 (EC50 = 7 µg/ml for both in E6SM cells), HIV-1 and HIV-2 (EC50s = 1.8 and 2.5 µg/ml, respectively, in CEM cells), and VZV (EC50 = 10 µg/ml in human embryonic lung fibroblasts); reduces increases in lymph node viral DNA and serum IgG levels in a mouse model of AIDS induced by infection with LP-BM5 at 50 mg/kg; inhibits tumor growth induced by MSV infection in mice at 50 mg/kg
Formal name: P-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-phosphonic acid
Synonyms: GS-0393|PMEA
Molecular weight: 273.2
CAS: 106941-25-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Nucleoside Reverse Transcriptase Inhibitors (NRTIs)||Product Type|Biochemicals|Nucleotides/Nucleosides||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Cancer||Research Area|Cardiovascular System|Blood|Serum Proteins||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Chicken Pox & Shingles||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS||Research Area|Infectious Disease|Viral Diseases|HSV